(Q33664574)

28 July 2017

1 reference

title

Plasmin activation system in restenosis: role in pathogenesis and clinical prediction? (English)

1 reference

28 July 2017

Christ G

1

1 reference

28 July 2017

Kostner K

2

1 reference

28 July 2017

Zehetgruber M

3

1 reference

28 July 2017

Binder BR

4

1 reference

28 July 2017

Gulba D

5

1 reference

28 July 2017

Huber K

6

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Journal of Thrombosis and Thrombolysis

28 July 2017

published in

1 reference

28 July 2017

volume

7

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

277-285

1 reference

Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors

28 July 2017

cites work

1 reference

12 December 2020

A potential basis for the thrombotic risks associated with lipoprotein(a).

1 reference

12 December 2020

Structural requirements for the growth factor activity of the amino-terminal domain of urokinase

1 reference

12 December 2020

Growth factor control of extracellular proteolysis

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

The plasminogen activator/plasmin system

1 reference

12 December 2020

Vascular interactions of lipoprotein (a).

1 reference

12 December 2020

Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo

1 reference

12 December 2020

Plasminogen activator inhibitor-1 levels in patients with chronic angina pectoris with or without angiographic evidence of coronary sclerosis

1 reference

12 December 2020

The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review

1 reference

12 December 2020

Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line

1 reference

12 December 2020

[Is plasma lipoprotein (a) level a reliable indicator predicting restenosis after angioplasty?]

1 reference

12 December 2020

Haemostatic function in myocardial infarction

1 reference

12 December 2020

Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors

1 reference

12 December 2020

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

1 reference

12 December 2020

Prevention of restenosis by bezafibrate after successful coronary angioplasty

1 reference

12 December 2020

Role of platelets in restenosis after percutaneous coronary revascularization

1 reference

12 December 2020

Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells

1 reference

12 December 2020

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

1 reference

12 December 2020

Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system

1 reference

12 December 2020

Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy

1 reference

12 December 2020

Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease

1 reference

12 December 2020

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

1 reference

12 December 2020

Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2

1 reference

12 December 2020

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen

1 reference

12 December 2020

Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

1 reference

12 December 2020

Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty

1 reference

12 December 2020

Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen

1 reference

12 December 2020

Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients

1 reference

12 December 2020

Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue

1 reference

12 December 2020

Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases

1 reference

12 December 2020

Tissue cooperation in a proteolytic cascade activating human interstitial collagenase

1 reference

12 December 2020

Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries

1 reference

12 December 2020

Making connections count

1 reference

12 December 2020

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

1 reference

12 December 2020

Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina

1 reference

12 December 2020

Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.

1 reference

12 December 2020

Proliferation of a human epidermal tumor cell line stimulated by urokinase

1 reference

12 December 2020

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

1 reference

12 December 2020

IFN-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cells.

1 reference

12 December 2020

Regulation of PAI-1 gene expression in vivo

1 reference

12 December 2020

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

12 December 2020

Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group

1 reference

12 December 2020

PAI-1 inhibits neointimal formation after arterial injury in mice: a new target for controlling restenosis?

1 reference

12 December 2020

The relevance of plasminogen activators to neoplastic growth. A review of recent literature.

1 reference

12 December 2020

Impaired fibrinolytic capacity and tissue plasminogen activator release in patients with restenosis after percutaneous transluminal coronary angioplasty (PTCA)

1 reference

12 December 2020

Growth factor-like effect of urokinase type plasminogen activator in human renal cells

1 reference

12 December 2020

Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients

1 reference

12 December 2020

Fibrinogen after coronary angioplasty as a risk factor for restenosis

1 reference

12 December 2020

The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein

1 reference

12 December 2020

Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoprotein

1 reference

12 December 2020

Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin

1 reference

12 December 2020

High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease

1 reference

12 December 2020

1 reference

12 December 2020

Coagulation activation in patients undergoing directional coronary atherectomy

1 reference

12 December 2020

Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cells

1 reference

12 December 2020

Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a)

1 reference

12 December 2020

Plasminogen activator inhibitor-1 plasma levels and coronary restenosis

1 reference

12 December 2020

Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells

1 reference

12 December 2020

A cascade model for restenosis. A special case of atherosclerosis progression

1 reference

12 December 2020

Lipoprotein Lp(a) and the risk for myocardial infarction

1 reference

12 December 2020

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

1 reference

12 December 2020

Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system

1 reference

12 December 2020

Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease

1 reference

12 December 2020

Apolipoprotein epsilon 4 homozygosity--a determinant of restenosis after coronary angioplasty.

1 reference

12 December 2020

Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease

1 reference

12 December 2020

Induction of PDGF-responsive genes in vascular smooth muscle. Implications for the early response to vessel injury

1 reference

12 December 2020

Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.

1 reference

12 December 2020

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation

1 reference

12 December 2020

Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris

1 reference

12 December 2020

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

1 reference

12 December 2020

Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin

1 reference

12 December 2020

Reproducibility of fibrinolytic response to venous occlusion in healthy subjects

1 reference

12 December 2020

Absence of a prothrombotic state in restenotic patients?

1 reference

12 December 2020

Inhibitors of fibrinolysis are elevated in atherosclerotic plaque

1 reference

12 December 2020

Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

12 December 2020

[Restenosis after percutaneous transluminal coronary angioplasty in the elderly--risk factor analysis]

1 reference

12 December 2020

Effects of LDL apheresis on restenosis after angioplasty

1 reference

12 December 2020

Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months

1 reference

12 December 2020

Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Regulation and role of urokinase plasminogen activator in vascular remodelling

1 reference

12 December 2020

Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion

1 reference

12 December 2020

A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis

1 reference

12 December 2020

Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries

1 reference

12 December 2020

Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008983110941

1 reference

Dimensions Publication ID

28 July 2017

1041909459

0 references

1 reference